Back

VJHemOnc is committed to improving our service to you

iwNHL 2015 | Therapeutic opportunities for lenalidomide in non-Hodgkin lymphoma

VJHemOnc is committed to improving our service to you

Nathan Fowler

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Nathan H. Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the ongoing clinical trials that are investigating the use of lenalidomide, an immunomodulatory drug, as monotherapy or in combination for the treatment of different subtypes of non-Hodgkin lymphoma.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter